{
  "id": 120768,
  "name": "NOVOCURE INC.",
  "slug": "novocure-inc",
  "state": "NH",
  "description": "Commercial stage oncology dedicated to advancement of TTF therapy to treat solid tumors",
  "totalSpending": 1540000,
  "filings": 14,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 250000
    },
    {
      "year": 2019,
      "income": 530000
    },
    {
      "year": 2020,
      "income": 420000
    },
    {
      "year": 2021,
      "income": 340000
    }
  ],
  "firms": [
    "FOLEY & LARDNER LLP"
  ],
  "lobbyists": [
    "MICHAEL CROSSEN",
    "MICHAEL CAPUANO"
  ],
  "issues": [
    "HCR",
    "CPT",
    "VET",
    "MMM",
    "INS",
    "SCI",
    "MAN",
    "BUD",
    "MED"
  ],
  "sampleDescriptions": [
    "Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.",
    "&#226;€‹Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.",
    "&#226;€‹Medical devices",
    "Medical devices"
  ],
  "years": [
    2018,
    2019,
    2020,
    2021
  ],
  "growthRate": 36,
  "trajectory": "growing",
  "yearsActive": 4,
  "avgAnnualSpending": 385000,
  "peakYear": 2019,
  "lobbyistCount": 2,
  "firmCount": 1,
  "issueCount": 9
}